Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA, commonly referred to as Merz, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Frankfurt, Germany. Established in 1908, the company has a long-standing history of innovation and growth, expanding its presence across major markets in Europe, North America, and beyond.
Specialising in aesthetic medicine, neurotoxins, and dermatology, Merz is recognised for its high-quality, scientifically advanced products that address both medical and aesthetic needs. Its core offerings include botulinum toxins, dermal fillers, and skincare solutions, distinguished by their safety profiles and efficacy. With a strong market position and a commitment to research, Merz continues to be a leader in delivering innovative healthcare solutions worldwide.
-16 vs industry average
Merz Pharma GmbH & Co. KGaA’s score of 24 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Merz Pharma GmbH & Co. KGaA?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Merz Pharma GmbH & Co. KGaA's reported carbon emissions
Merz Pharma GmbH & Co. KGaA, a pharmaceutical preparation manufacturer headquartered in Germany, reported approximately 215,948,000 kg CO2e in total carbon emissions for 2024. This figure encompasses Scope 1, 2, and 3 emissions.
Of the total, approximately 214,200,000 kg CO2e were attributed to Scope 3 emissions. Key contributors within Scope 3 include purchased goods and services, accounting for about 24,544,000 kg CO2e, and upstream transportation and distribution at approximately 3,487,000 kg CO2e. Scope 1 emissions were around 1,358,000 kg CO2e, while Scope 2 emissions, using market-based reporting, stood at approximately 390,000 kg CO2e.
Merz Pharma's emissions data is cascaded from the ultimate parent organization, Merz Pharma GmbH & Co. KGaA, as part of a corporate family relationship where Merz Pharma GmbH & Co. KGaA is a current subsidiary at cascade level 2. No specific reduction targets or achievements were detailed for this reporting period.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Merz Pharma GmbH & Co. KGaA’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Merz Pharma GmbH & Co. KGaA yet.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Merz Pharma GmbH & Co. KGaA
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project